Adverse Events Spark FDA Evaluation Of Topical Acne Ingredients
This article was originally published in The Rose Sheet
Executive Summary
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
You may also be interested in...
OTC Acne Treatment Labels Should Add Sensitivity Test Direction – FDA
Manufacturers of OTC topical acne drug products should consider including text on labeling that instructs new uses in sensitivity testing “to reduce the risk of serious hypersensitivity reactions,” FDA says.
Natural OTCs Sprout From Firms’ Innovations Within Monograph Limits
Recently launched OTCs from Earth’s Care and LaCorium Health target consumers who want natural products with the safety and efficacy assured under FDA’s drug monographs. Supplement and homeopathic product makers also target consumers with natural alternatives to traditional pharmaceuticals.
Natural OTCs Sprout From Firms’ Innovations Within Monograph Limits
Recently launched OTCs from Earth’s Care and LaCorium Health target consumers who want natural products with the safety and efficacy assured under FDA’s drug monographs. Supplement and homeopathic product makers also target consumers with natural alternatives to traditional pharmaceuticals.